摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-bromo-1-[4-chloro-3-(N-benzyl-N-methylsulfonylamino)]phenylethanone | 296238-42-1

中文名称
——
中文别名
——
英文名称
2-bromo-1-[4-chloro-3-(N-benzyl-N-methylsulfonylamino)]phenylethanone
英文别名
N-benzyl-N-[5-(2-bromoacetyl)-2-chlorophenyl]methanesulfonamide
2-bromo-1-[4-chloro-3-(N-benzyl-N-methylsulfonylamino)]phenylethanone化学式
CAS
296238-42-1
化学式
C16H15BrClNO3S
mdl
——
分子量
416.723
InChiKey
USGNYXVAZRHALB-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.7
  • 重原子数:
    23
  • 可旋转键数:
    6
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.19
  • 拓扑面积:
    62.8
  • 氢给体数:
    0
  • 氢受体数:
    4

反应信息

  • 作为产物:
    描述:
    四丁基溴化铵 、 4'-chloro-3'-(N-benzyl-N-methylsulfonylamino)acetophenone 以 1,4-二氧六环 为溶剂, 生成 2-bromo-1-[4-chloro-3-(N-benzyl-N-methylsulfonylamino)]phenylethanone
    参考文献:
    名称:
    Method for manufacturing tricyclic amino alcohol derivatives
    摘要:
    本发明涉及用于制备一种用于治疗糖尿病、肥胖、高脂血症等的化合物的过程,该化合物由以下式(1)表示:其中R1代表较低的烷基或苄基;*1代表不对称碳原子;R2代表氢原子、卤素原子或羟基;A代表以下一种基团:其中X代表NH、O或S;R6代表氢原子、羟基、氨基或乙酰氨基;*2代表不对称碳原子,当R6不是氢原子时,以及对所述过程有用的中间体。本发明的过程是方便、实用、成本低廉的制备过程,包括少量步骤和良好的工业工作效率。
    公开号:
    US06495701B1
点击查看最新优质反应信息

文献信息

  • Process for preparing optically active secondary alcohols having nitrogenous or oxygenic functional groups
    申请人:——
    公开号:US20030045727A1
    公开(公告)日:2003-03-06
    A process for preparing optically active secondary alcohols of the general formula (3), [wherein R 1 is linear lower alkyl, an aromatic ring group, or the like; A is CH 2 NR 2 R 3 or the like; n is an integer of 0 to 2; and * represents an asymmetric carbon atom] by asymmetrically hydrogenating a ketone compound of the general formula (1) having nitrogenous or oxygen functional group at any of the a-, &bgr;- and &ggr;-positions, with selectivity among functional groups by the use of a ruthenium/optically active bidentate phosphine/diamine complex as the catalyst in the presence of hydrogen alone or together with a base. The optically active secondary alcohols obtained by the process are useful as drugs and intermediates for the preparation of drugs.
    通过使用/光学活性双齿膦/二胺配合物作为催化剂,在存在氢气的情况下或与碱一起,通过不对称地氢化具有氮或氧官能团在α、β和γ位置中的酮化合物(1)来制备通式(3)的光学活性二级醇,[其中R1是线性低碳烷基、芳香环基等;A是CH2NR2R3或类似物;n是0到2的整数;*代表不对称碳原子]。通过该过程获得的光学活性二级醇可用作药物及药物中间体的制备。
  • NOVEL METHOD FOR MANUFACTURING TRICYCLIC AMINO ALCOHOL DERIVATIVES
    申请人:Asahi Kasei Kabushiki Kaisha
    公开号:EP1174425A1
    公开(公告)日:2002-01-23
    The present invention is directed to processes for the preparation of a compound useful for treating and preventing diabetes, obesity, hyperlipidemia and the like, which compound is represented by the formula (1) : wherein R1 represents a lower alkyl group or a benzyl group; ∗1 represents an asymmetric carbon atom; R2 represents a hydrogen atom, a halogen atom or a hydroxyl group; and A represents one of the following groups: wherein X represents NH, O or S; R6 represents a hydrogen atom, a hydroxyl group, an amino group or an acetylamino group; and ∗2 represents an asymmetric carbon atom when R6 is not a hydrogen atom, and to intermediates useful for the said processes. The processes of the present invention are convenient, practical preparing processes with low cost which comprise a small number of steps with good industrial work efficiency.
    本发明涉及一种用于治疗和预防糖尿病、肥胖症、高脂血症等的化合物的制备工艺,该化合物由式(1)表示: 其中 R1 代表低级烷基或苄基;∗1 代表不对称碳原子;R2 代表氢原子、卤素原子或羟基;A 代表下列基团之一: 其中 X 代表 NH、O 或 S;R6 代表氢原子、羟基、基或乙酰基;当 R6 不是氢原子时,∗2 代表不对称碳原子。本发明的工艺是方便实用的制备工艺,成本低,步骤少,工业生产效率高。
  • PROCESS FOR PREPARING OPTICALLY ACTIVE SECONDARY ALCOHOLS HAVING NITROGENOUS OR OXYGENIC FUNCTIONAL GROUPS
    申请人:Asahi Kasei Kabushiki Kaisha
    公开号:EP1254885A1
    公开(公告)日:2002-11-06
    The present invention provides a process for the preparation of an optically active secondary alcohol represented by the general formula (3): wherein R1 represents a straight-chain lower alkyl group, an aromatic ring group, or the like; A represents CH2NR2R3, or the like; n is an integer of from 0 to 2; and * represents an asymmetric carbon atom, which comprises asymmetrically hydrogenating with selectivity among the functional groups, a ketone compound represented by the general formula (1) having a nitrogenous or oxygenic functional group at any of the α-, β- and γ-positions: wherein R1, A and n are as defined above, using a ruthenium/optically active bidentate phosphine/diamine complex as a catalyst in the presence of hydrogen or in the presence of hydrogen and a base. The optically active secondary alcohols obtained by the present process are useful as medicaments and intermediates for producing medicaments.
    本发明提供了一种由通式(3)表示的光学活性仲醇的制备方法: 其中 R1 代表直链低级烷基、芳香环基或类似基团;A 代表 CH2NR2R3 或类似基团;n 是 0 至 2 的整数;以及 * 代表不对称碳原子,其包括以官能团之间的选择性不对称氢化通式 (1) 所代表的酮化合物,该酮化合物在 α-、β- 和 γ- 位置上具有含氮或含氧官能团: 其中 R1、A 和 n 如上定义,使用/光学活性双齿膦/二胺络合物作为催化剂,在氢气存在下或在氢气和碱存在下进行。 通过本工艺获得的光学活性仲醇可用作药物和生产药物的中间体。
  • US6495701B1
    申请人:——
    公开号:US6495701B1
    公开(公告)日:2002-12-17
查看更多